Skip to content

Repligen

US · RGEN #1445 by market cap Listed 1970
163.81 -6.48 -3.81%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 40 in the most recent period (2026/Q3).
  • Total institutional ownership fell 5.3 percentage points.

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
118.27% -5.26pp
Institutions
607 +40
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund93.86%
Hedge Fund11.99%
Private Company5.01%
Public Company3.86%
Government Pension Fund1.47%
Sovereign Wealth Fund0.90%
VC/PE Fund0.40%
Family Office/Trust0.30%
Insurance Company0.29%
Individual/Insider0.32%

Top holders as of 2026-09-30

FMR 11.50% · 7.35M sh
BlackRock 8.96% · 5.73M sh
T. Rowe Price Group, Inc. 4.95% · 3.16M sh
United Capital Financial Advisors 4.37% · 2.79M sh
Roy T Eddleman Living Trust Uad 08/17/2000 4.23% · 2.71M sh
Vanguard Capital Management, LLC 3.82% · 2.44M sh
Vanguard Portfolio Management, LLC 3.55% · 2.27M sh
Maverick Capital, Ltd. 3.10% · 1.98M sh
State Street Global Advisors 2.89% · 1.85M sh
MFS Investment Management 2.53% · 1.62M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 30 buys · 20 sells

NameRoleStake
Karen Dawes Former Independent Director 0.14%
Glenn Muir Independent Director 0.06%
Ralf Kuriyel Officer 0.01%
James Bylund Chief Operating Officer 0.01%
Martin Madaus Independent Chairperson 0.01%
Carrie Eglinton Manner Independent Director 0.01%
Nicholas Barthelemy Independent Director 0.01%
Rohin Mhatre Independent Director 0.01%
Jason Garland CFO & Chief Compliance Officer 0.01%
Konstantin Konstantinov Member of Scientific Advisory Board & Independent Director 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-05 Brian Douglass Senior VP & Chief Product Officer Other Acquisition +700 --
2026-10-05 Brian Douglass Senior VP & Chief Product Officer Other Derivative Acquisition +675 $174.86
2026-10-04 Olivier Loeillot Chief Executive Officer Open Market Disposition -1,333 $178.75
2026-10-04 Olivier Loeillot President & Chief Commercial Officer Intent to Sell (Form 144) -4,202 $190.00
2026-10-04 Olivier Loeillot President & Chief Commercial Officer Intent to Sell (Form 144) -1,333 $178.75
2026-10-04 Olivier Loeillot Chief Executive Officer Derivative Exercise and Sale -4,202 $154.96–190.00
2026-10-01 Olivier Loeillot Chief Executive Officer Sale to Issuer -1,248 $181.70
2026-09-24 Jason Garland CFO & Chief Compliance Officer Sale to Issuer -421 $189.68
2026-09-23 Olivier Loeillot Chief Executive Officer Derivative Exercise and Sale -12,946 $154.96–190.00
2026-09-20 Olivier Loeillot Chief Executive Officer Derivative Exercise and Sale -5,426 $141.79–180.00
2026-09-03 Olivier Loeillot Chief Executive Officer Automatic Disposition -3,035 $165.90
2026-09-02 Olivier Loeillot Chief Executive Officer Sale to Issuer -2,842 $169.61
2026-08-31 Violetta Hughes Chief Accounting Officer Sale to Issuer -277 $170.02
2026-08-19 Olivier Loeillot Chief Executive Officer Derivative Exercise and Sale -5,426 $141.79–180.00
2026-07-15 Jason Garland CFO & Chief Compliance Officer Automatic Disposition -530 $150.00
2026-06-24 Jason Garland CFO & Chief Compliance Officer Automatic Disposition -733 $145.00
2026-05-13 Glenn Muir Independent Director Other Acquisition +995 --
2026-05-13 Glenn Muir Independent Director Other Derivative Acquisition +2,239 $103.38
2026-05-13 Martin Madaus Independent Chairperson Other Acquisition +995 --
2026-05-13 Martin Madaus Independent Chairperson Other Derivative Acquisition +2,239 $103.38

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Repligen discussion 0 comments

Add a comment